Startup · $4m raised
Perth, WA
Every investor coverage indicates participated in a round SynGenis Pty Ltd raised.
Companies SynGenis Pty Ltd acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Thomas Hanly | Managing Director | Dealroom (23 Sep 2026), becomerichfaster.com, SMH Business, Dealroom (13 Jul 2026) |
Stories naming SynGenis Pty Ltd. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A new precision-medicine company formed by Perth's Syngenis Labs, a research institute and two scientists has bought Gene S, maker of the Rosa pharmacogenomics tool; no price was disclosed.
SynGenis, a Perth biotech, has raised A$4 million in an oversubscribed pre-seed round arranged through Euroz Hartleys, to build an AI platform for RNA and DNA medicines ahead of a planned stock listing.
Roundup of Australian manufacturing news: OncoSil, K-TIG and Aurora Labs complete or commit raises, Amplia opens an offer, Siemens agrees to buy Altair, CSIRO unveils a printed-solar facility, and a WA medical alliance grows.
Western Australia's government has awarded $8.5 million in grants across three schemes, a health innovation seed fund, commercialisation bridge grants and innovation booster grants, naming dozens of local recipients.